Frankfurt am Main, Germany

Thomas Olpp

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: The Innovative Contributions of Thomas Olpp

Introduction

Thomas Olpp is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of six patents to his name, Olpp's work focuses on enhancing the efficacy of treatments for various diseases.

Latest Patents

Among his latest patents, Olpp has developed conjugates comprising a GLP-1/Glucagon dual agonist, a linker, and hyaluronic acid. This invention relates to a conjugate or a pharmaceutically acceptable salt that includes a GLP-1/Glucagon receptor agonist, a linker, and a hyaluronic acid hydrogel. The invention aims to provide pharmaceutical compositions that can be used as medicaments for treating or preventing diseases that can be addressed by GLP-1/Glucagon receptor agonists. Another significant patent involves prodrugs comprising a GLP-1/Glucagon dual agonist linker hyaluronic acid conjugate. This prodrug is designed to enhance the therapeutic potential of GLP-1/Glucagon agonists, further contributing to the advancement of medical treatments.

Career Highlights

Thomas Olpp is currently employed at Sanofi, a global leader in the pharmaceutical industry. His work at Sanofi has allowed him to focus on innovative drug development, contributing to the company's mission of improving patient health through advanced therapies.

Collaborations

Olpp has collaborated with esteemed colleagues such as Dieter Kadereit and Michael Wagner. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of groundbreaking pharmaceutical solutions.

Conclusion

In summary, Thomas Olpp's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…